Darwin Global Management as of June 30, 2021
Portfolio Holdings for Darwin Global Management
Darwin Global Management holds 12 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Intellia Therapeutics (NTLA) | 48.6 | $301M | 1.9M | 161.91 | |
| Acceleron Pharma | 35.6 | $221M | 1.8M | 125.49 | |
| Fate Therapeutics (FATE) | 4.7 | $29M | 336k | 86.79 | |
| Bridgebio Pharma (BBIO) | 3.3 | $21M | 337k | 60.96 | |
| Beam Therapeutics (BEAM) | 2.6 | $16M | 127k | 128.71 | |
| Verve Therapeutics (VERV) | 1.0 | $6.2M | 103k | 60.25 | |
| Inhibrx | 1.0 | $6.2M | 226k | 27.52 | |
| Essa Pharma Com New (EPIX) | 1.0 | $6.0M | 209k | 28.57 | |
| Keros Therapeutics (KROS) | 0.7 | $4.4M | 104k | 42.47 | |
| Aclaris Therapeutics (ACRS) | 0.7 | $4.4M | 250k | 17.56 | |
| Relay Therapeutics (RLAY) | 0.7 | $4.4M | 120k | 36.59 | |
| Generation Bio (GBIO) | 0.0 | $289k | 11k | 26.91 |
